WASHINGTON—Very small pancreatic cystic tumors are safe to observe, rather than treat, in patients with no symptoms and no radiographic features associated with malignancy, according to a study of patients with neoplasms less than 3 cm in size.
Recent international consensus guidelines suggest that patients with these small tumors do not need immediate treatment. However, there have been few published data up to now to support that recommendation. The purpose of this study was to determine the rate of malignancy among patients with pancreatic cystic tumors less than 3 cm and the incidence of symptoms and radiographic features suggesting malignancy.
The researchers found that about 3.3% of patients with very small tumors and no symptoms or radiographic features had a malignant tumor. As a result, "we have concluded that the international guidelines are appropriate," commented C. J. Lee, MD, of the University of Michigan Medical School, Ann Arbor, who presented the findings at Digestive Disease Week 2007 (abstract 278).
Led by Diane Simeone, MD, the researchers used databases from five high-volume pancreatic centers to identify 166 resected neoplasms less than 3 cm in size. For each neoplasm, they looked at predictors of malignancy, such as age, sex, and symptoms, including abdominal pain, nausea and vomiting, jaundice, pancreatitis, unexplained weight loss, and anorexia.
The investigators also reviewed radiographic features of concern, including the presence of a mass, lymphadenopathy, or dilated main pancreatic or common bile ducts.
Of the 166 cases identified, 31 were malignant. Men and older patients were more likely to have malignant tumors, Dr. Lee reported.
The great majority of patients with malignancy (96%) had symptoms, including abdominal pain (55%), weight loss (35%), jaundice (32%), and pancreatitis (14%). Most also had at least one radiographic feature of concern.
